Journal article
Evolving management of patients treated by drug-eluting stent: Prevention of late events
- Abstract:
-
Summary: Drug eluting stents (DES) were introduced in clinical practice to overcome the problem of in-stent restenosis (ISR) that limited the overall efficacy of percutaneous coronary revascularization with bare metal stent (BMS). Long-term outcome data confirm a sustained benefit of DES as compared with BMS. However, this benefit is mainly evident in the first year of follow-up. Indeed, DES-related events may extend over this time, due to late events (late ISR and/or very late stent thrombos...
Expand abstract
Actions
Authors
Bibliographic Details
- Publisher:
- Elsevier
- Journal:
- Cardiovascular Revascularization Medicine
- Volume:
- 15
- Issue:
- 2
- Pages:
- 100-108
- Publication date:
- 2014-01-01
- DOI:
- EISSN:
-
1878-0938
- ISSN:
-
1553-8389
- Source identifiers:
-
460200
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:460200
- UUID:
-
uuid:111fa77e-ed51-419d-a8d3-2f85be5877f9
- Local pid:
- pubs:460200
- Deposit date:
- 2014-08-22
Terms of use
- Copyright date:
- 2014
If you are the owner of this record, you can report an update to it here: Report update to this record